Mechanism of FHIT-Induced Apoptosis in Lung Cancer Cell Lines

Background:The FHIT (fragile histidine triad) gene is a frequent target of deletions associated with abnormal RNA and protein expression in lung cancer. Previous studies have shown FHIT gene transfer into lung cancer cell line lacking FHIT protein expression resulted in inhibition of tumor cell growth attributable to the induction of apoptosis and reversion of tumorigenecity. However, the mechanism of the tumor suppressor activity of the FHIT gene and the cellular pathways associated with its function are not completely understood.Methods:To gain insight into the biological function of FHIT, we compared the NCI-H358 cell line with its stable FHIT transfectants after treatment with cisplatin or paclitaxel. We investigated the effects of FHIT gene expression on cell proliferation, apoptosis, and activation of caspase system and Bcl-2 family. The induction of apoptosis was evaluated by using DAPI staining and flow cytometry. Activation of caspases and Bcl-2 members was evaluated by Western blot analysis.Results:A significantly increased cell death was observed in FHIT transfectants after cisplatin or paclitaxel treatment and this was attributable to the induction of apoptosis. Remarkable changes in caspases and Bcl-2 family were observed in the transfected cells as compared with the control cells after treatment with paclitaxel. Activation of caspase-3 and caspase-7 was markedly increased in cells expressing FHIT. Expression level of Bcl-2 and Bcl-xL protein was significantly decreased and that of Bax and Bad protein was significantly increased in the transfected cells.Conclusion:FHIT gene delivery into lung cancer cells results in enhanced apoptosis induced by treatment with cisplatin or paclitaxel. The data suggest that apoptosis in FHIT-expressing cells could be related to activation of caspase pathway and Bcl-2 family.(Tuberculosis and Respiratory Diseases 2004, 56:450-464)

keywords: Fragile histidine triad (FHIT), Apoptosis, Lung neoplasms, Paclitaxel, Cisplatin.

Reference

Molecular analysis of the short arm of chromosome 3 in small-cell and non- small-cell carcinoma of the lung,

(1987) Loss of heterozygosity of chroꠀ mosome 3p markers in small-cell lung cancer,

Loss of heterozygosity on chroꠀ 17 in small cell carcinoma and on chromosome 3 in adenocarcinoma of the lung,

(1992) Three distinct regions involved in 3p deletions in human lung cancer,

characteristic of malignant lung tumors are detectable in preinvasive lesions of the bronchus,

(1995) Allele- specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma,

(1992) Definition of a tumor suppressor locus within human chromosome 3p21-p22,

(oncogene1993) A homozygous deletion on chroꠀ mosome 3 in a small cell lung cancer cell line correlates with a region of tumor supꠀ, pressor activity

(1993) A gene in the chromosomal region 3p21 with greatly reduced expression in lung cancer is similar to the gene for ubiquitin activation enzyme,

10.

(1994) Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines,

11.

(1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma- associated t(3;8) breakpoint, is abnormal in digestive tract cancers,

12.

(1996) Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines,

13.

(1996) Aberꠀrant FHIT transcripts in Merkel cell carꠀcinoma,

14.

(1996) The FHIT gene at 3p14.2 is abnormal in breast carcinomas,

15.

(1996) FHIT gene alterations in head and neck squamous cell carcinomas,

16.

(1986) The most common fragile site in man is 3p14,

17.

(1995) Cloning of the Schizosaccharomyces pombe gene encoding diadenosine 5'5'''-P1,P4-tetraphoꠀsphate (Ap4A) asymmetrical hydrolase: sequeꠀnce similarity with histidine triad (HIT) familyCloning of the Schizosaccharomyces pombe gene encoding diadenosine 5'5'''-P1 nce similarity with histidine triad(HIT) family,

18.

(1996) Fhit, a putative tumor suppressor in humans, is a dinuꠀcleoside 5', 5'''-P1,P3 triphosphate hydrolase,

19.

(1996) The FHIT gene at 3p14.2 is abnormal in lung cancer,

20.

(1996) Molecular analysis of the FHIT gene at 3p14 2 in lung cancer cell lines,

21.

(1997) Rassool FV, Zimmerman PV, Giaccone G, Gazdar AF, Minna JD. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial leꠀsions and are associated with cancer-related FHIT cDNA splicing aberrations,

22.

(1997) Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities,

23.

(1999) The tumor-supꠀpressor gene FHIT is involved in the regulaꠀtion of apoptosis and in cell cycle control,

24.

(1999) Induction of apoptosis and inhiꠀbition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histiꠀdine triad (FHIT) gene overexpression,

25.

(2002) Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cerꠀvical cancer cell lines,

26.

(2001) Effect of adenoviral transduction of the fragile histiꠀdine triad gene into esophageal cancer cells,

27.

(2001) During MJ, Huebner K, Croce CM. Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer,

28.

(2003) Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines,

29.

(2004) Implication of mitoꠀchondrial involvement in apoptotic activity of fragile histidine triad gene: application of synchronous luminescence spectroscopy,

바로가기메뉴

Article Contents

Vol.56 No.5

Mechanism of FHIT-Induced Apoptosis in Lung Cancer Cell Lines

Abstract

Reference

Tuberculosis & Respiratory Diseases